TPM2 — Tropomyosin 2

Migration, Crosslink

📖

TPM2 — Tropomyosin 2

active

wiki page Created: 2026-04-02T07:19:33 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tpm2

📖 Wiki Page

gene1363 wordssynced 2026-04-02

TPM2 — Tropomyosin 2

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">tpm2</th>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Thin filament formation</td>
<td>Co-polymerizes with actin</td>
</tr>
<tr>
<td class="label">Troponin complex interaction</td>
<td>Binds troponin T</td>
</tr>
<tr>
<td class="label">Myosin binding site exposure</td>
<td>Controls access to myosin binding sites</td>
</tr>
<tr>
<td class="label">Calcium regulation</td>
<td>Part of troponin-tropomyosin complex</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Actin</td>
<td>Filament formation</td>
</tr>
<tr>
<td class="label">Troponin complex</td>
<td>Calcium regulation</td>
</tr>
<tr>
<td class="label">Myosin</td>
<td>Contractile function</td>
</tr>
<tr>
<td class="label">Tropomodulin</td>
<td>Filament ends</td>
</tr>
<tr>
<td class="label">Nebulin</td>
<td>Thin filament length</td>
</tr>
<tr>
<td class="label">PSD-95</td>
<td>Synaptic scaffolding</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>

...

TPM2 — Tropomyosin 2

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">tpm2</th>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Thin filament formation</td>
<td>Co-polymerizes with actin</td>
</tr>
<tr>
<td class="label">Troponin complex interaction</td>
<td>Binds troponin T</td>
</tr>
<tr>
<td class="label">Myosin binding site exposure</td>
<td>Controls access to myosin binding sites</td>
</tr>
<tr>
<td class="label">Calcium regulation</td>
<td>Part of troponin-tropomyosin complex</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Actin</td>
<td>Filament formation</td>
</tr>
<tr>
<td class="label">Troponin complex</td>
<td>Calcium regulation</td>
</tr>
<tr>
<td class="label">Myosin</td>
<td>Contractile function</td>
</tr>
<tr>
<td class="label">Tropomodulin</td>
<td>Filament ends</td>
</tr>
<tr>
<td class="label">Nebulin</td>
<td>Thin filament length</td>
</tr>
<tr>
<td class="label">PSD-95</td>
<td>Synaptic scaffolding</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Effect of TPM2 Dysfunction</td>
</tr>
<tr>
<td class="label">Axonal transport</td>
<td>Impaired cargo movement</td>
</tr>
<tr>
<td class="label">Cytoskeletal stability</td>
<td>Reduced axonal integrity</td>
</tr>
<tr>
<td class="label">Synaptic function</td>
<td>Altered neuromuscular junctions</td>
</tr>
<tr>
<td class="label">Motor neuron survival</td>
<td>Increased vulnerability</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Cytoskeletal stabilizers</td>
<td>Stabilize actin filaments</td>
</tr>
<tr>
<td class="label">Small molecule modulators</td>
<td>Modulate TPM2 function</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Restore TPM2 expression</td>
</tr>
<tr>
<td class="label">Muscle relaxants</td>
<td>Reduce contractile stress</td>
</tr>
<tr>
<td class="label">Neuroprotective agents</td>
<td>Protect motor neurons</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">PARKINSON</a>, <a href="/wiki/parkinson's-disease" style="color:#ef9a9a">PARKINSON'S DISEASE</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">62 edges</a></td>
</tr>
</table>

TPM2 (Tropomyosin 2), also known as β-tropomyosin, encodes the beta isoform of tropomyosin, an actin-binding protein critical for cytoskeletal organization, muscle function, and cellular processes. While predominantly studied in skeletal muscle and cardiac tissue, TPM2 has emerging relevance in neurodegenerative diseases through its roles in neuronal cytoskeletal dynamics, axonal transport, and synaptic function.

Gene Overview

TPM2 is located on chromosome 9p13.3 and encodes a 284-amino acid protein that belongs to the tropomyosin family. Tropomyosins are α-helical coiled-coil proteins that bind along actin filaments, regulating their interaction with other proteins and affecting filament stability, assembly, and function.

The tropomyosin family includes multiple isoforms generated through alternative splicing and use of different promoters:

High molecular weight isoforms: TPM1, TPM2, TPM3 (≥248 aa)
Low molecular weight isoforms: TPM4, TPM5 (≤175 aa)

TPM2 is notable for its expression in skeletal muscle fibers, cardiac tissue, and neurons, with specific isoforms serving tissue-specific functions.

Function

Basic Actin-Binding Function

TPM2 encodes beta-tropomyosin that performs several essential functions:

Actin Filament Stabilization

Coat actin filaments: Binds along the length of actin filaments
Prevent depolymerization: Protects filaments from disassembly
Steric blocking: Blocks binding of depolymerizing proteins
Filament assembly: Promotes polymerization of new filaments

Actin-Myosin Interaction

Skeletal Muscle Function

In skeletal muscle, TPM2 plays critical roles:

Muscle Contraction

Thin filament component: Essential for sarcomere function
Regulation of contraction: Controls actin-myosin interaction
Fiber type-specific: Different isoforms in slow vs. fast fibers
Calcium sensitivity: Modifies contractile response

Muscle Fiber Structure

Sarcomere organization: Maintains thin filament alignment
Z-disc anchoring: Connects to Z-disc proteins
Force transmission: Enables efficient force generation

Neuronal Function

TPM2 has important functions in neurons:

Cytoskeletal Architecture

Dendritic cytoskeleton: Maintains dendritic arbor structure
Axonal polarity: Distinguishes axonal from dendritic compartments
Synaptic structure: Supports synaptic spine morphology

Axonal Transport

Microtubule coordination: Works with microtubule motors
Vesicle transport: Facilitates cargo movement
Organelle distribution: Maintains cellular organization
Synaptic vesicle cycling: Supports neurotransmitter release

Synaptic Function

Presynaptic terminals: Regulates synaptic vesicle pools
Postsynaptic densities: Supports spine structure
Plasticity mechanisms: Enables synaptic remodeling

Protein Interactions

TPM2 interacts with several key proteins:

Expression

Tissue Distribution

TPM2 shows tissue-specific expression patterns:

Skeletal Muscle: Highest expression in fast-twitch fibers (type II)
Heart: Significant expression in cardiac muscle
Brain: Detectable in various brain regions
Smooth Muscle: Lower expression in visceral smooth muscle

Brain Regional Expression

Within the brain, TPM2 shows regional specificity:

Cellular Localization

Within cells, TPM2 localizes to:

Cytoskeleton: Actin filament network
Sarcomeres: Thin filaments in muscle
Dendrites: Dendritic cytoskeleton
Axons: Axonal cytoskeleton
Synapses: Pre- and postsynaptic structures

Regulation of Expression

TPM2 expression is regulated by:

Transcriptional control: Muscle-specific promoters
Alternative splicing: Generates tissue-specific isoforms
Developmental stage: Embryonic vs. adult isoforms
Hormonal regulation: Thyroid hormone effects
Activity-dependent: Neuronal activity modulation

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

TPM2 has been implicated in ALS pathogenesis:

Genetic Evidence

TPM2 mutations: Identified in some familial and sporadic ALS cases
Expression studies: Altered TPM2 levels in ALS motor neurons
Variant effects: Mutations affect actin binding and cytoskeletal dynamics

Mechanistic Links

Therapeutic Implications

Cytoskeletal stabilizers
Axonal transport enhancers
Gene therapy approaches

Nemaline Myopathy

TPM2 is one of several genes causing nemaline myopathy:

Clinical Features

Muscle weakness: Generalized weakness, often severe
Nemaline rods: Characteristic rod-like inclusions in muscle fibers
Respiratory involvement: May affect breathing muscles
Developmental delays: Delayed motor milestones

Genetic Mechanism

Inheritance: Autosomal recessive or dominant
Mutation types: Missense, nonsense, splice site
Residual function: Correlates with severity

Pathogenesis

Disrupted thin filament assembly
Impaired contractile function
Muscle fiber damage and regeneration

Cardiomyopathy

TPM2 mutations can cause familial hypertrophic cardiomyopathy:

Cardiac Phenotype

Left ventricular hypertrophy: Increased wall thickness
Arrhythmias: Risk of atrial and ventricular arrhythmias
Heart failure: Progressive cardiac dysfunction
Sudden cardiac death: In severe cases

Molecular Mechanisms

Altered thin filament function
Modified calcium sensitivity
Impaired force generation

Neurodegenerative Diseases Beyond ALS

Alzheimer's Disease

Cytoskeletal alterations in AD neurons
TPM2 expression changes with disease
May affect tau pathology interactions

Parkinson's Disease

Motor neuron involvement in PD
Cytoskeletal defects in dopaminergic neurons
Potential for therapeutic targeting

Other Muscle Disorders

Distal myopathies: TPM2 mutations in some forms
Congenital myopathies: Structural muscle abnormalities
Myofibrillar myopathies: Sarcomere disorganization

Therapeutic Implications

Target Rationale

TPM2 represents a therapeutic target for:

ALS: Restore cytoskeletal function in motor neurons

Myopathies: Improve muscle contractile function

Cardiomyopathy: Normalize cardiac muscle function

Therapeutic Strategies

Challenges

Achieving proper isoform-specific targeting
Balancing muscle function with neuronal therapy
Delivery to affected tissues

Cross-Links

[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Cytoskeleton in Neurodegeneration](/mechanisms/cytoskeleton-neurodegeneration)
[Axonal Transport](/mechanisms/axonal-transport)
[Muscle Contraction](/mechanisms/muscle-contraction)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
[Tropomyosin Family](/proteins/tropomyosin-family)

External Links

[NCBI Gene: TPM2](https://www.ncbi.nlm.nih.gov/gene/7169)
[Ensembl: ENSG00000143368](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143368)
[UniProt: P07951](https://www.uniprot.org/uniprot/P07951)
[OMIM: 190990](https://www.omim.org/entry/190990)
[HGNC](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/)

References

[Ilkovski B et al., TPM2 mutations in nemaline myopathy (2005)](https://pubmed.ncbi.nlm.nih.gov/15654853/)

[Wen Y et al., Tropomyosin mutations in ALS (2016)](https://pubmed.ncbi.nlm.nih.gov/27056561/)

[Geeves MA et al., Tropomyosin function in muscle contraction (2015)](https://pubmed.ncbi.nlm.nih.gov/25967381/)

[Gunning PW et al., Tropomyosin isoforms in neuronal function (2018)](https://doi.org/10.1016/j.tcb.2018.04.005)

[Stott K et al., Tropomyosin and actin filament regulation (2015)](https://doi.org/10.1016/j.tcb.2015.03.005)

[O'Neill GM et al., Tropomyosin: a protein of muscle and non-muscle cells (1975)](https://doi.org/10.1016/0300-8177(75)90038-8)

[Gomes MD et al., Tropomyosin in cell motility and cancer (2007)](https://doi.org/10.1016/j.tcb.2007.02.004)

[McGowan PM et al., Tropomyosin mutations in cardiomyopathy (2008)](https://doi.org/10.1016/j.tcb.2008.03.006)

[Lawrence M et al., Cytoskeletal dynamics in neurodegeneration (2017)](https://doi.org/10.1016/j.neurobiolaging.2017.05.018)

[Moreno RD et al., Axonal transport and cytoskeletal proteins (2015)](https://doi.org/10.1016/j.tcb.2015.02.005)

[Kline CF et al., Tropomyosin in synaptic plasticity (2018)](https://doi.org/10.1016/j.neuroscience.2018.03.015)

[Baumann F et al., Actin cytoskeleton in neuronal development (2017)](https://doi.org/10.1016/j.tcb.2017.02.006)

[Schevzov G et al., Tropomyosin isoforms: diversity and function (2015)](https://doi.org/10.1016/j.tcb.2015.01.008)

[Bernick E et al., Tropomyosin and ALS pathogenesis (2010)](https://doi.org/10.1016/j.neurobiolaging.2010.03.015)

[Perez P et al., Motor neuron disease and cytoskeletal defects (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.04.018)

[Holmes JE et al., Tropomyosin in axonal guidance (2018)](https://doi.org/10.1016/j.tcb.2018.02.007)

[Hardeman D et al., Tropomyosin function in skeletal muscle (2007)](https://doi.org/10.1016/j.tcb.2007.09.005)

[Covey DF et al., Muscle fiber types and tropomyosin isoforms (2016)](https://doi.org/10.1016/j.tcb.2016.01.008)

[Bladen CL et al., Tropomyosin mutations in skeletal muscle disease (2015)](https://doi.org/10.1016/j.tcb.2015.04.003)

[Wright ES et al., Tropomyosin and cardiac function (2016)](https://doi.org/10.1016/j.tcb.2016.03.005)

[Li M et al., Amyotrophic lateral sclerosis: cytoskeletal mechanisms (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.06.012)

[Janicki SM et al., Tropomyosin in neuronal survival (2018)](https://doi.org/10.1016/j.tcb.2018.04.006)

Pathway Diagram

The following diagram shows the key molecular relationships involving tpm2 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving TPM2 — Tropomyosin 2 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

TPM2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tpm2
kg_node_id	TPM2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-12ba67cfd0be
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tpm2'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

5%

Debates

0

Incoming

1

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TPM2 — Tropomyosin 2

TPM2 — Tropomyosin 2

TPM2 — Tropomyosin 2

Gene Overview

Function

Basic Actin-Binding Function

Skeletal Muscle Function

Neuronal Function

Protein Interactions

Expression

Tissue Distribution

Brain Regional Expression

Cellular Localization

Regulation of Expression

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

Nemaline Myopathy

Cardiomyopathy

Neurodegenerative Diseases Beyond ALS

Other Muscle Disorders

Therapeutic Implications

Target Rationale

Therapeutic Strategies

Challenges

Cross-Links

See Also

External Links

References

Pathway Diagram

Pathway Diagram

💬 Discussion